dipyridamole has been researched along with cardiovascular agents in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (33.33) | 18.7374 |
| 1990's | 11 (33.33) | 18.2507 |
| 2000's | 5 (15.15) | 29.6817 |
| 2010's | 6 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grosse, G; Lindner, G; Plonka, G | 1 |
| Ioannou, P; Talesnik, J | 1 |
| Giessler, C; Mentz, P; Mest, HJ; Pawelsky, KE | 1 |
| Block, HU; Förster, W; Giessler, C; Heinroth, I; Mentz, P; Pönicke, K; Rettkowski, W; Zehl, U | 1 |
| Hu, GJ; Jiang, WD; Wei, PJ; Zhang, JG | 1 |
| Giessler, C; Mentz, P; Pawelski, KE | 1 |
| Jacobi, H; Jentzsch, KR; Lüdtke, W; Schwarz, H | 1 |
| Engelstein, ED; Lerman, BB | 1 |
| Borgeat, P; Krump, E; Lemay, G | 1 |
| Heinz, M; Söhngen, M; Theiss, W; van de Flierdt, E | 1 |
| Bigi, R | 1 |
| Delabar, U; Eckardt, KU; Freudenthaler, S; Gleiter, CH; Gundert-Remy, U; Mühlbauer, B; Osswald, H | 1 |
| Alabovskiĭ, VV; Vinokurov, AA | 1 |
| Baumgartner, H; Binder, T; Christ, G; Maurer, G; Mörtl, D; Mundigler, G; Porenta, G; Probst, P; Siostrzonek, P; Zehetgruber, M | 1 |
| Joksimović, J; Juranić, I; Juranić, Z; Radulović, S | 1 |
| Baldwin, SA; Cass, CE; Griffiths, M; Ng, AM; Sundaram, M; Yao, SY; Young, JD | 1 |
| Hesse, B; Mortensen, J; Toft, J | 1 |
| Barnett, SD; Golden, AG; Hamdan, K; Llorente, M; Preston, RA; Silverman, MA | 1 |
| Bombardini, T; Borghi, B; Fedriga, P; Gaggini, G; Garberoglio, B; Marcelli, E; Picano, E; Plicchi, G | 1 |
| Chapelon-Abric, C | 1 |
| Baer, F; de Roos, A; Fleck, E; Hundley, WG; Lorenz, C; Nagel, E; Neubauer, S; Pennell, DJ; Pettigrew, R; Sechtem, U; van der Wall, E; van Rossum, A; Wickline, S; Wilke, N | 1 |
| Hayes, SN; McBride, P | 1 |
| LERCHE, D; NEUHAUS, G; SCHUCK, P | 1 |
| KOHLER, H | 1 |
| LUISADA, AA; NEUMANN, M | 1 |
| KNABE, J | 1 |
| Dounis, V; Hansen, A; Malmberg, K; Rydén, L; Thrainsdottir, IS; Von Bibra, H | 1 |
| Badano, LP; Del Mestre, L; Ermacora, D; Gianfagna, P; Muraru, D; Proclemer, A; Rigo, F | 1 |
| Barzegar, A | 1 |
| Cohn, S; Deller, R; Edwards, D; Fletcher, K; Giles, M; Hobbs, V; Lasserson, D; Mant, J; McGuire, G; McManus, R; Norrie, J; Sims, D; Weir, C; Whittle, F | 1 |
| Abbink, EJ; Bouw, TP; Coenen, MJ; Donders, AR; El Messaoudi, S; Kievit, PC; Noyez, L; Peters, JG; Pickkers, P; Rasing-Hoogveld, A; Riksen, NP; Rongen, GA; van Swieten, HA; Wouters, CW | 1 |
| Liu, Y; Wu, X; Yu, Z | 1 |
| Al Badarin, F; Bateman, TM; Case, JA; Chan, PS; Courter, S; Heller, GV; Kennedy, KF; McGhie, AI; Patel, KK; Spertus, JA | 1 |
4 review(s) available for dipyridamole and cardiovascular agents
| Article | Year |
|---|---|
Complications of pharmacologic stress echocardiography in coronary artery disease.
Topics: Adenosine; Cardiotonic Agents; Cardiovascular Agents; Coronary Disease; Dipyridamole; Dobutamine; Echocardiography; Exercise Test; Humans; Vasodilator Agents | 1996 |
[Cardiac sarcoidosis].
Topics: Anti-Inflammatory Agents; Biopsy; Cardiomyopathies; Cardiomyopathy, Restrictive; Cardiovascular Agents; Death, Sudden, Cardiac; Dipyridamole; Echocardiography; Electrocardiography; Heart Block; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Sarcoidosis; Steroids; Tachycardia, Ventricular; Vasodilator Agents | 2001 |
Stress cardiovascular magnetic resonance: consensus panel report.
Topics: Adenosine; Cardiovascular Agents; Contrast Media; Coronary Artery Disease; Dipyridamole; Dobutamine; Exercise Test; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Monitoring, Physiologic; Myocardial Ischemia | 2001 |
[CHEMISTRY OF CARDIAC DRUGS].
Topics: Alkaloids; Anti-Arrhythmia Agents; Cardiovascular Agents; Coumarins; Digitalis Glycosides; Dipyridamole; Humans; Nitrates; Nitrites; Phenols; Prenylamine; Procainamide; Quinidine; Rauwolfia; Vasodilator Agents | 1964 |
6 trial(s) available for dipyridamole and cardiovascular agents
| Article | Year |
|---|---|
[The effect of Taprostene on platelet activation and clinical course after percutaneous transluminal angioplasty].
Topics: Administration, Oral; Adult; Aged; Angioplasty, Balloon; Arterial Occlusive Diseases; Aspirin; Cardiovascular Agents; Dipyridamole; Drug Therapy, Combination; Epoprostenol; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Pilot Projects; Platelet Activation; Recurrence; Treatment Outcome | 1996 |
Erythropoietin production in healthy volunteers subjected to controlled haemorrhage: evidence against a major role for adenosine.
Topics: Adenosine; Adult; Area Under Curve; Cardiovascular Agents; Creatinine; Dipyridamole; Erythropoietin; Hematocrit; Hemoglobins; Hemorrhage; Humans; Male; Phlebotomy; Phosphodiesterase Inhibitors; Single-Blind Method; Theophylline | 1996 |
High volume-rate three-dimensional stress echocardiography to assess inducible myocardial ischemia: a feasibility study.
Topics: Aged; Aged, 80 and over; Cardiovascular Agents; Coronary Artery Disease; Dipyridamole; Echocardiography; Echocardiography, Stress; Echocardiography, Three-Dimensional; Feasibility Studies; Female; Heart; Humans; Male; Middle Aged; Myocardial Ischemia | 2010 |
RApid Primary care Initiation of Drug treatment for Transient Ischaemic Attack (RAPID-TIA): study protocol for a pilot randomised controlled trial.
Topics: Antihypertensive Agents; Aspirin; Cardiovascular Agents; Clinical Protocols; Dipyridamole; Drug Administration Schedule; Drug Therapy, Combination; Emergency Service, Hospital; England; Feasibility Studies; General Practice; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Attack, Transient; Pilot Projects; Primary Health Care; Referral and Consultation; Research Design; Secondary Prevention; Simvastatin; Time Factors; Treatment Outcome | 2013 |
Effect of dipyridamole on myocardial reperfusion injury: A double-blind randomized controlled trial in patients undergoing elective coronary artery bypass surgery.
Topics: Aged; AMP Deaminase; Biomarkers; Cardiovascular Agents; Coronary Artery Bypass; Dipyridamole; Double-Blind Method; Elective Surgical Procedures; Female; Genotype; Humans; Inflammation Mediators; Male; Middle Aged; Myocardial Reperfusion Injury; Netherlands; Pharmacogenetics; Phenotype; Time Factors; Treatment Outcome; Troponin I; Up-Regulation | 2016 |
Randomized Comparison of Clinical Effectiveness of Pharmacologic SPECT and PET MPI in Symptomatic CAD Patients.
Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Agents; Comparative Effectiveness Research; Coronary Angiography; Coronary Artery Disease; Coronary Circulation; Coronary Stenosis; Dipyridamole; Female; Health Status; Humans; Kansas; Male; Middle Aged; Myocardial Perfusion Imaging; Myocardial Revascularization; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prospective Studies; Purines; Pyrazoles; Referral and Consultation; Severity of Illness Index; Single Photon Emission Computed Tomography Computed Tomography; Time Factors; Treatment Outcome; Vasodilator Agents | 2019 |
23 other study(ies) available for dipyridamole and cardiovascular agents
| Article | Year |
|---|---|
[The effects of certain psycho- and coronary therapeutic agents on nerve tissue in vitro].
Topics: Animals; Cardiovascular Agents; Cells, Cultured; Dipyridamole; Ganglia; Hippocampus; Meclofenamic Acid; Nerve Tissue; Piracetam; Prenylamine; Psychotropic Drugs; Rats | 1978 |
Platelet antiaggregatory substances inhibit arachidonic acid induced coronary constriction.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Arachidonic Acid; Arachidonic Acids; Cardiovascular Agents; Coronary Circulation; Dipyridamole; Epoprostenol; Guinea Pigs; Heart; Hydralazine; Iloprost; In Vitro Techniques; Male; Nifedipine; Perfusion; Platelet Aggregation; Rats; Rats, Inbred Strains; Vasoconstriction | 1986 |
[Thromboxane A2 antagonistic effect of antiangina drugs, with special reference to trapidil and trapidil derivatives].
Topics: Anesthesia; Angina Pectoris; Animals; Anti-Arrhythmia Agents; Blood Pressure; Cardiovascular Agents; Coronary Vessels; Dipyridamole; Guinea Pigs; In Vitro Techniques; Muscle Contraction; Muscle, Smooth, Vascular; Myocardial Contraction; Pyrimidines; Rabbits; Thromboxane A2; Trapidil | 1987 |
Influence of cardiovascular drugs on platelet aggregation.
Topics: Animals; Cardiovascular Agents; Dipyridamole; Epoprostenol; Humans; Myocardium; Nitroglycerin; Nitroprusside; Nonachlazine; Platelet Aggregation; Propranolol; Rabbits; Rats; Trapidil | 1983 |
[Effects of intracoronary injections of sodium tanshinone II-A sulfonate and dipyridamole on myocardial infarct size in acute ischemic dogs (author's transl)].
Topics: Animals; Cardiovascular Agents; Coronary Vessels; Dipyridamole; Dogs; Female; Furans; Male; Myocardial Infarction; Phenanthrenes | 1981 |
Drug induced inhibition of the cardiac effects of U 46619 as a thromboxane A2-like agonist.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Blood Pressure; Cardiovascular Agents; Dipyridamole; Guinea Pigs; Heart; Heart Atria; Myocardial Contraction; Propranolol; Prostaglandin Endoperoxides, Synthetic; Trapidil; Verapamil | 1984 |
[Interaction of coronary-active compounds and anti-inflammatory drugs on the coronary vascular system (author's transl)].
Topics: Animals; Anti-Inflammatory Agents; Cardiovascular Agents; Chromonar; Coronary Circulation; Coumarins; Dipyridamole; Dogs; Drug Interactions; Female; Indoleacetic Acids; Indomethacin; Male; Morpholines; Myocardium; Oxygen Consumption | 1981 |
Increased defibrillation threshold due to ventricular fibrillation duration. Potential mechanisms.
Topics: Adenosine; Adrenergic Antagonists; Animals; Autonomic Nervous System; Cardiovascular Agents; Denervation; Dipyridamole; Dogs; Electric Countershock; Epinephrine; Lactates; Myocardium; Norepinephrine; Nucleosides; Time Factors; Vagotomy; Ventricular Fibrillation | 1995 |
Adenosine A2 receptor-induced inhibition of leukotriene B4 synthesis in whole blood ex vivo.
Topics: Adenosine; Cardiovascular Agents; Dipyridamole; Humans; Leukotriene B4; Lipopolysaccharides; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Platelet Aggregation Inhibitors; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Tumor Necrosis Factor-alpha | 1996 |
[The protective action of adenosine in the development of the "calcium paradox" in the isolated heart].
Topics: Adenosine; Animals; Calcium; Cardiovascular Agents; Dipyridamole; Dose-Response Relationship, Drug; Heart; In Vitro Techniques; Myocardial Reperfusion; Myocardium; Myoglobin; Perfusion; Rats; Theophylline | 1997 |
Transesophageal versus intracoronary Doppler measurements for calculation of coronary flow reserve.
Topics: Adenosine; Cardiovascular Agents; Coronary Angiography; Coronary Circulation; Coronary Disease; Dipyridamole; Echocardiography, Doppler; Echocardiography, Transesophageal; Female; Humans; Male; Middle Aged; Sensitivity and Specificity; Ultrasonography, Interventional; Vasodilator Agents | 1997 |
Adenosine contributes to the amine oxidase-mediated spermine cytotoxicity to human myelogenous leukemia K562 cells.
Topics: Adenosine; Adrenergic beta-Agonists; Albuterol; Aminophylline; Cardiotonic Agents; Cardiovascular Agents; Cell Survival; Dipyridamole; Drug Synergism; Humans; Leukemia, Myeloid; Oxidoreductases Acting on CH-NH Group Donors; Spermine; Tumor Cells, Cultured; Vasodilator Agents | 1998 |
Chimeric constructs between human and rat equilibrative nucleoside transporters (hENT1 and rENT1) reveal hENT1 structural domains interacting with coronary vasoactive drugs.
Topics: Affinity Labels; Amino Acid Sequence; Animals; Binding Sites; Cardiovascular Agents; Carrier Proteins; Dipyridamole; Equilibrative Nucleoside Transport Proteins; Equilibrative Nucleoside Transporter 1; Humans; Membrane Proteins; Molecular Sequence Data; Oocytes; Protein Conformation; Protein Structure, Secondary; Rats; Recombinant Fusion Proteins; Thioinosine; Vasodilator Agents; Xenopus | 1998 |
Risk of atrioventricular block during adenosine pharmacologic stress testing in heart transplant recipients.
Topics: Adenosine; Adolescent; Adult; Cardiovascular Agents; Dipyridamole; Dose-Response Relationship, Drug; Exercise Test; Female; Heart Block; Heart Transplantation; Humans; Infusions, Intravenous; Male; Middle Aged; Postoperative Complications; Risk Factors | 1998 |
Inappropriate medication prescribing in homebound older adults.
Topics: Aged; Aged, 80 and over; Amitriptyline; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Cardiovascular Agents; Cross-Sectional Studies; Dipyridamole; Doxepin; Drug Prescriptions; Drug Utilization; Ergoloid Mesylates; Female; Histamine H1 Antagonists; Homebound Persons; Humans; Hypnotics and Sedatives; Male; Medication Errors; Middle Aged; Nootropic Agents; Polypharmacy; Practice Patterns, Physicians'; Prevalence; Pyridines; Temazepam; Vasodilator Agents; Zolpidem | 1999 |
Operator independent left ventricular function monitoring during pharmacological stress echo with the new peak transcutaneous acceleration signal.
Topics: Acceleration; Cardiovascular Agents; Dipyridamole; Dobutamine; Echocardiography; Electrocardiography; Exercise Test; Feasibility Studies; Heart Ventricles; Humans; Monitoring, Physiologic; Myocardial Contraction; Ventricular Function; Ventricular Function, Left | 2001 |
Diagnosing coronary heart disease: when to use stress imaging studies.
Topics: Adenosine; Cardiotonic Agents; Cardiovascular Agents; Coronary Angiography; Coronary Disease; Dipyridamole; Dobutamine; Echocardiography; Exercise Test; Family Practice; Female; Humans; Male; Middle Aged; Radionuclide Imaging; Referral and Consultation; Risk Factors; United States; Vasodilator Agents | 2003 |
[The hypoxia test in evaluation of coronary-active drugs, especially of persantin in man].
Topics: Cardiovascular Agents; Coronary Vessels; Dipyridamole; Hypoxia; Vasodilator Agents | 1961 |
Recently introduced cardiovascular drugs under experimental test.
Topics: Cardiovascular Agents; Coronary Vessels; Dipyridamole; Humans; Prenylamine; Vasodilator Agents | 1963 |
EFFECT OF RAPID AND SLOW-ACTING "CORONARY" DRUGS ON PRECORDIAL PAIN OF THE AGED.
Topics: Angina Pectoris; Cardiovascular Agents; Chest Pain; Chlordiazepoxide; Dipyridamole; Electrocardiography; Geriatrics; Humans; Pentaerythritol Tetranitrate; Prenylamine | 1964 |
Tissue Doppler imaging for the detection and quantitation of myocardial dysfunction in patients with type 2 diabetes mellitus.
Topics: Age Factors; Aged; Cardiomyopathies; Cardiovascular Agents; Diabetes Mellitus, Type 2; Diastole; Dipyridamole; Dobutamine; Echocardiography, Doppler, Pulsed; Echocardiography, Stress; Female; Humans; Male; Middle Aged; Myocardial Contraction; Systole | 2005 |
Proton-coupled electron-transfer mechanism for the radical scavenging activity of cardiovascular drug dipyridamole.
Topics: Animals; Antioxidants; Cardiovascular Agents; Cell Line; Cell Survival; Dipyridamole; Electron Transport; Free Radicals; Oxidation-Reduction; Rats; Reactive Oxygen Species | 2012 |
Ginkgo leaf extract and dipyridamole injection as adjuvant treatment for acute cerebral infarction: Protocol for systemic review and meta-analysis of randomized controlled trials.
Topics: Acute Disease; Adjuvants, Pharmaceutic; Cardiovascular Agents; Cerebral Infarction; Clinical Protocols; Dipyridamole; Ginkgo biloba; Humans; Meta-Analysis as Topic; Plant Extracts; Randomized Controlled Trials as Topic; Systematic Review as Topic; Treatment Outcome | 2019 |